Search

everythinglearnresearchcommunity

for

Search:↓

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

MK-5108 is safe and shows potential against tumors, especially alone.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

A cancer patient's hair became permanently curly after treatment with nivolumab.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

The Sacred Heart Bilobed Flap is a surgical method for repairing small scalp defects with local flaps, relying on scalp elasticity and hair regrowth to hide any imperfections.

Loose anagen hair syndrome causes easily shed hair but usually improves with time.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Letrozole may help prevent seizures by reducing certain hormone levels.

Compound 4 is a promising treatment for hair loss with low toxicity.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Entospletinib effectively prevents eye and skin GVHD in mice.

ALRN-6924 may prevent hair loss caused by chemotherapy.